X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MYLAN
Dec-14
ALKEM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,5894,254-   
Low Rs1,2322,998-   
Sales per share (Unadj.) Rs417.51,456.2-  
Earnings per share (Unadj.) Rs56.3175.4-  
Cash flow per share (Unadj.) Rs64.7282.4-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9723.9-  
Shares outstanding (eoy) m119.57378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.42.5 135.7%   
Avg P/E ratio x25.120.7 121.2%  
P/CF ratio (eoy) x21.812.8 169.8%  
Price / Book Value ratio x4.85.0 96.1%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,371,817 12.3%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM22,039.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,655.0-  
INCOME DATA
Net Sales Rs m49,915550,976 9.1%  
Other income Rs m1,645-3,212 -51.2%   
Total revenues Rs m51,561547,765 9.4%   
Gross profit Rs m8,482137,030 6.2%  
Depreciation Rs m1,00640,467 2.5%   
Interest Rs m67123,766 2.8%   
Profit before tax Rs m8,45169,586 12.1%   
Minority Interest Rs m-114-285 39.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,926 54.9%   
Profit after tax Rs m6,73166,374 10.1%  
Gross profit margin %17.024.9 68.3%  
Effective tax rate %19.04.2 451.9%   
Net profit margin %13.512.0 111.9%  
BALANCE SHEET DATA
Current assets Rs m27,062484,381 5.6%   
Current liabilities Rs m15,324378,689 4.0%   
Net working cap to sales %23.519.2 122.6%  
Current ratio x1.81.3 138.1%  
Inventory Days Days6778 85.2%  
Debtors Days Days41107 38.5%  
Net fixed assets Rs m12,610127,467 9.9%   
Share capital Rs m23919,484 1.2%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,027273,890 12.8%   
Long term debt Rs m1,212409,164 0.3%   
Total assets Rs m54,3871,103,202 4.9%  
Interest coverage x13.63.9 346.3%   
Debt to equity ratio x01.5 2.3%  
Sales to assets ratio x0.90.5 183.8%   
Return on assets %13.68.2 166.6%  
Return on equity %19.224.2 79.3%  
Return on capital %24.913.6 182.4%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,25972,426 10.0%  
From Investments Rs m1,864-57,117 -3.3%  
From Financial Activity Rs m-9,273-19,084 48.6%  
Net Cashflow Rs m-150-3,775 4.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.37 Rs / USD

Compare ALKEM LABORATORIES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: SANOFI INDIA  DISHMAN PHARMA  DR. DATSONS LABS  FULFORD INDIA  PIRAMAL ENTERPRISES  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Feb 15, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS